News
November 1, 2007. Intrucept Biomedicine relocates company headquarters to Owensboro, KY. New business address becomes 3700 Airpark Drive, Suite 1, Owensboro, KY 42301, USA.
January 2, 2007. Intrucept Biomedicine renews commercial license from NIH covering Griffithsin technology and improvements.
September 1, 2006. Intrucept Biomedicine expands fields on NIH commercial license to include devices, non-regulated R&D reagents.
May 4, 2006. Intrucept Biomedicine completes first-round private financing. Proceeds to be used for in-licensing and operational activities.
April 5, 2006. Intrucept Biomedicine acquires license from National Institutes of Health to develop and commercialize novel class of antiviral biotherapeutic.
January 6, 2006. Intrucept Biomedicine founded in California as a Limited Liability Company.
3700 Airpark Drive, Suite 1